HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric Hollander Selected Research

Clomipramine (Anafranil)

4/2006Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
8/2003A review of pharmacologic treatments for obsessive-compulsive disorder.
2/2003Review: in obsessive-compulsive disorder, clomipramine may be more effective than selective serotonin reuptake inhibitors after controlling for other factors.
10/2002World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric Hollander Research Topics

Disease

30Autism Spectrum Disorder
01/2022 - 01/2003
28Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
01/2022 - 04/2002
27Autistic Disorder (Autism)
11/2022 - 01/2003
14Gambling (Pathological Gambling)
12/2014 - 07/2002
10Body Dysmorphic Disorders (Body Dysmorphic Disorder)
01/2021 - 04/2002
7Anxiety Disorders (Anxiety Disorder)
01/2022 - 10/2002
5Asperger Syndrome (Asperger's Syndrome)
12/2011 - 01/2003
4Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
03/2013 - 11/2002
4Borderline Personality Disorder (Personality Disorders, Borderline)
10/2011 - 03/2005
4Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2008 - 06/2003
4Social Phobia
11/2006 - 04/2002
3Feeding and Eating Disorders (Eating Disorder)
11/2009 - 04/2002
3Personality Disorders (Personality Disorder)
02/2008 - 06/2003
3Substance-Related Disorders (Drug Abuse)
01/2008 - 10/2005
2COVID-19
01/2022 - 06/2021
2Prader-Willi Syndrome (Syndrome, Prader-Willi)
01/2021 - 01/2018
2Schizophrenia (Dementia Praecox)
04/2018 - 11/2008
2Neurodevelopmental Disorders
09/2015 - 01/2014
2Tic Disorders (Tic Disorder)
10/2014 - 11/2009
2Bipolar Disorder (Manic Depressive Psychosis)
03/2014 - 04/2006
2Anorexia
03/2009 - 02/2008
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
11/2008 - 10/2005
1Anosmia
06/2021
1Central Nervous System Infections (Central Nervous System Infection)
06/2021
1Infections
06/2021
1Ageusia (Hypogeusia)
06/2021
1Nocturia
01/2021
1Hyperphagia (Overeating)
01/2021
1Chronic Disease (Chronic Diseases)
07/2019
1Inborn Genetic Diseases (Disease, Hereditary)
01/2018
1Multiple Sclerosis
06/2016
1Neuroinflammatory Diseases
09/2015
1Depressive Disorder (Melancholia)
03/2014
1Fragile X Syndrome (Martin Bell Syndrome)
01/2014
1Tics (Tic)
06/2010
1Cognitive Dysfunction
01/2010
1Parkinson Disease (Parkinson's Disease)
11/2009
1Compulsive Personality Disorder (Obsessive Compulsive Personality)
11/2009
1Tourette Syndrome (Tourette's Syndrome)
11/2009
1Chorea (Rheumatic Chorea)
11/2009
1Trichotillomania
11/2009
1Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections
11/2009

Drug/Important Bio-Agent (IBA)

24Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2022 - 10/2002
16Serotonin (5 Hydroxytryptamine)IBA
03/2014 - 11/2002
10Oxytocin (Pitocin)FDA LinkGeneric
01/2021 - 01/2003
9Valproic Acid (Depakote)FDA LinkGeneric
03/2010 - 07/2002
8CitalopramFDA LinkGeneric
01/2022 - 08/2003
87,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA
01/2021 - 04/2002
6Fluvoxamine (Luvox)FDA LinkGeneric
07/2010 - 06/2003
5LithiumIBA
12/2014 - 07/2002
5Norepinephrine (Noradrenaline)FDA LinkGeneric
06/2012 - 08/2003
5Fluoxetine (Prozac)FDA LinkGeneric
03/2012 - 01/2004
4Biomarkers (Surrogate Marker)IBA
12/2020 - 08/2017
4Pharmaceutical PreparationsIBA
12/2020 - 07/2008
4Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
02/2008 - 10/2002
4Clomipramine (Anafranil)FDA LinkGeneric
04/2006 - 10/2002
4Risperidone (Risperdal Consta)FDA LinkGeneric
01/2006 - 08/2003
3Glucose (Dextrose)FDA LinkGeneric
04/2018 - 07/2006
3Anticonvulsants (Antiepileptic Drugs)IBA
04/2014 - 11/2006
3Topiramate (Topamax)FDA LinkGeneric
03/2013 - 05/2006
3ProlactinIBA
12/2010 - 09/2004
3nalmefene (Revex)FDA Link
10/2010 - 02/2006
3Dopamine (Intropin)FDA LinkGeneric
12/2009 - 08/2003
3Hydrocortisone (Cortisol)FDA LinkGeneric
02/2008 - 12/2006
3BenzodiazepinesIBA
01/2008 - 10/2002
3Paroxetine (Paxil)FDA LinkGeneric
05/2006 - 09/2003
2balovaptanIBA
11/2022 - 01/2022
2Biological FactorsIBA
06/2021 - 01/2005
2Antipsychotic Agents (Antipsychotics)IBA
01/2019 - 08/2003
2(6- chloro- 1- (2- (dimethylamino)ethyl)indol- 3- yl)- spiro(1H- isobenzofuran- 3,4'- piperidine)- 1'- yl- methanoneIBA
08/2017 - 08/2017
2Vasopressins (Vasopressin)IBA
08/2017 - 08/2017
2Ondansetron (Zofran)FDA LinkGeneric
03/2014 - 12/2009
2Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
12/2011 - 07/2006
2Peptides (Polypeptides)IBA
07/2010 - 01/2003
2EscitalopramFDA Link
06/2010 - 03/2006
2Neurotransmitter Agents (Neurotransmitter)IBA
05/2008 - 08/2003
21-(3-chlorophenyl)piperazineIBA
12/2006 - 09/2004
2Sertraline (Zoloft)FDA LinkGeneric
03/2006 - 08/2003
2Lithium Carbonate (Eskalith)FDA LinkGeneric
01/2005 - 07/2002
1CytokinesIBA
01/2022
1Biological ProductsIBA
06/2021
1Immunologic Factors (Immunomodulators)IBA
01/2020
1Peptide Hormones (Polypeptide Hormones)IBA
01/2018
1Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
08/2017
1Fingolimod Hydrochloride (FTY720)FDA Link
06/2016
1Ionotropic Glutamate ReceptorsIBA
01/2014
1Pregabalin (Lyrica)FDA Link
06/2012
1volinanserinIBA
12/2011
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
12/2011
1A-factor (Streptomyces)IBA
01/2011
1Sumatriptan (Imigran)FDA LinkGeneric
12/2010
1Growth Hormone (Somatotropin)IBA
12/2010
1NeuropeptidesIBA
07/2010
1Arginine Vasopressin (Argipressin)IBA
07/2010
1L 644711 (B-3(+))IBA
06/2010

Therapy/Procedure

10Therapeutics
07/2019 - 08/2003
9Drug Therapy (Chemotherapy)
07/2019 - 08/2003
4Transcranial Magnetic Stimulation
01/2022 - 03/2014
3Secondary Prevention
07/2019 - 09/2003
1Mesenchymal Stem Cell Transplantation
09/2015